skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

73 Total results for product and free and sample content found

Generics Bulletin

Corporate Strategies of the biggest Generics and Biosimilar players

17 Sep 2019

Understand the latest Corporate Strategies of the biggest Generics and Biosimilar players.

Topic Business strategies

In Vivo

Personalised Medicine: Treating the individual patient

17 Sep 2019

With more individualized treatments, such as cell and gene therapies, coming to market every day, In Vivo can keep you up to date on the diversity within clinical R&D, trials, the latest trends and the barriers that still exist within personalised medicine. We’ve pulled together information covering the increasing focus of personalized medicine in clinical R&D and the future trends of precision medicine. 

Topic Personalized Medicine


Biomedtracker: Improved Custom Company Portfolio Feature

04 Sep 2019

Discover how creating custom company portfolios can help you overcome your toughest business challenges. 

Topic Business strategies


Meddevicetracker: New Company Portfolio Feature

04 Sep 2019

Meddevicetracker now gives you to the ability to find and follow partners or competitors and track their key activities. Quickly and easily identify new partners and keep tabs on your competition with the portfolio feature in Meddevicetracker.

Topic Business strategies Company analysis

Generics Bulletin

Executive and market moves interviews for exclusive insider knowledge

04 Sep 2019

Get in the side track on the Generics market with executive and market-moves interviews for exclusive insider knowledge. 

Topic Business strategies

Datamonitor Healthcare

Reimbursement and Payer Management of Immune Checkpoint Inhibitors

03 Sep 2019

As immune checkpoint inhibitors continue to gain approvals in expanded patient populations, payers express concern surrounding the potential budget impact of the drug class. Considering the high costs of these treatments in comparison to standard chemotherapy, HTA and reimbursement agencies stress the requirement for solid survival data and highlight that price will be a major factor during negotiations

Topic Drug review


QIDP: What have we GAINed?

By Jonathan Slater 02 Sep 2019

The Generating Antibiotic Incentives Now (GAIN) Act passed into law on July 9, 2012. Seven years on, we review the drugs that have obtained QIDP status, the companies involved, and the clinical trial landscape.

Topic Drug development landscape Drug review

In Vivo

In Vivo Content - Relied Upon by Senior Decision Makers

21 Aug 2019

There are many ways to market your brand and establish your business as a thought leader - but none of these methods compare to the distinct advantage gained through marketing with In Vivo and Informa Pharma Intelligence. The articles, news and interviews we feature are used daily by senior decision-makers to support their decisions, and to keep abreast of what their competitors are doing. 

Topic Business strategies Medtech

Datamonitor Healthcare

NASH Disease Coverage Extract

16 Aug 2019

Datamonitor Healthcare recently surveyed 60 gastroenterologists in the US and five major EU markets after the approval of the first disease-specific therapies for the treatment of non-alcoholic steatohepatitis (NASH). The market for these treatments will exceed $21bn in 2027.   

Topic Drug development landscape Diseases

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: